HEPCVEL TABLET 28'S

HEPCVEL TABLET 28'S has shown efficacy in treating hepatitis C in individuals with advanced liver disease or compensated cirrhosis. However, the response rate may vary, and close monitoring of liver function is important during and after treatment.

Yes, regular blood tests are typically conducted during HEPCVEL TABLET 28'S treatment to monitor liver function, viral load, and treatment response. These tests help assess the effectiveness of the medication and ensure patient safety.

HEPCVEL TABLET 28'S can be used in patients with mild to moderate kidney impairment without dose adjustment. However, patients with severe renal impairment or end-stage renal disease may require dose adjustments or alternative treatment options. It is important to discuss your kidney function with your healthcare provider to determine the most appropriate treatment plan.

HEPCVEL TABLET 28'S is effective and safe in individuals with both hepatitis C and HIV co-infection. However, it is important to coordinate treatment with both infectious disease and HIV specialists to ensure proper management of both conditions.

Weight gain or loss is not commonly reported as a side effect of HEPCVEL TABLET 28'S. However, individual responses to medication can vary. If you experience any unexplained or concerning changes in weight during treatment, it is recommended to consult your healthcare provider for further evaluation.

HEPCVEL TABLET 28'S can be used in patients with a history of liver transplantation who have recurrent hepatitis C. However, individual patient factors and the specific post-transplantation period must be considered. Consultation with a transplant hepatologist or specialist is recommended to determine the most appropriate treatment approach.

While HEPCVEL TABLET 28'S is generally well-tolerated, like any medication, it can potentially cause side effects. Common side effects include headache, fatigue, nausea, and insomnia. Serious side effects are rare but can include severe allergic reactions, changes in heart rate, and liver problems. It is important to discuss any concerns or potential side effects with your healthcare provider, who can provide further information and guidance based on your specific situation.

It's important to inform your healthcare provider about all your current medications, as HEPCVEL TABLET 28'S can interact with other drugs. Special monitoring is needed if you are taking amiodarone due to the risk of severe bradycardia (slow heart rate).

Before starting treatment, you should be screened for Hepatitis B (HBV) infection. Close monitoring of liver function and HBV levels is necessary, especially if you have current or prior HBV infection. Dose adjustments may be needed if you have severe kidney problems. Discuss any history of psychiatric disorders, as well as pregnancy and breastfeeding plans, with your doctor.

HEPCVEL TABLET 28'S contains the active ingredients SOFOSBUVIR and VELPATASVIR.

HEPCVEL TABLET 28'S is used to treat chronic Hepatitis C virus (HCV) infection.

SOFOSBUVIR and VELPATASVIR are antiviral medications that work by preventing the Hepatitis C virus from multiplying in the body, helping to clear the infection.